ResMed Inc. Common Stock (NY:RMD)

218.89 UNCHANGED

Delayed Quote Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ResMed Inc. Common Stock

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

20 21 Next >

FDA Identifies ResMed's Recall Of Certain Ventilator Device Masks With Magnets As Most Serious ↗

January 12, 2024

ResMed (NYSE: RMD) recalls certain respiratory masks with magnets due to potential interference with medical devices. FDA Class I recall.

Via Benzinga

Topics Product Recall

If You Invested $100 In This Stock 15 Years Ago, You Would Have $900 Today ↗

January 10, 2024

Via Benzinga

Demystifying ResMed: Insights From 5 Analyst Reviews ↗

January 09, 2024

Via Benzinga

HCA Healthcare Rallies: Weight-loss drugs really a big threat?

January 08, 2024

HCA Healthcare rebounds amid concerns about weight-loss drugs' impact. The healthcare giant's revenue growth hints at resilience despite sector challenges.

Via MarketBeat

Topics ETFs

Top Picks 2024: ResMed ↗

January 07, 2024

ResMed is the market leader in continuous positive airway pressure machines. ResMed has enjoyed a steadily growing market throughout its history, and investors have often paid sky-high valuations for...

Via Talk Markets

Uncovering Dividend Opportunities with NYSE:RMD. ↗

December 26, 2023

Why RESMED INC (NYSE:RMD) qualifies as a good dividend investing stock.

Via Chartmill

$1000 Invested In ResMed 15 Years Ago Would Be Worth This Much Today ↗

December 25, 2023

Via Benzinga

(RMD) - Analyzing ResMed's Short Interest ↗

December 22, 2023

Via Benzinga

If You Invested $1000 In This Stock 20 Years Ago, You Would Have $17,000 Today ↗

December 14, 2023

Via Benzinga

ResMed to Report Second Quarter Fiscal 2024 Earnings on January 24, 2024

January 03, 2024

From ResMed Inc.

Via GlobeNewswire

ResMed Announces Participation in the 42nd Annual J.P. Morgan Healthcare Conference

December 27, 2023

From ResMed Inc.

Via GlobeNewswire

ResMed Notifies Customers About Updated Instructions and Labeling for Masks with Magnets Due to Potential Interference with Certain Medical Devices

December 20, 2023

ResMed’s masks with magnets are safe when used in accordance with the updated Instructions for Use

From ResMed Inc.

Via GlobeNewswire

Why NYSE:RMD qualifies as a good dividend investing stock. ↗

November 30, 2023

Is RESMED INC (NYSE:RMD) a Good Fit for Dividend Investing?

Via Chartmill

Why the dividend investor may take a look at NYSE:RMD. ↗

November 08, 2023

Analyzing RESMED INC (NYSE:RMD)'s Dividend Potential.

Via Chartmill

ResMed Secures Significant Victory in Patent Fight Against New York University

December 11, 2023

From ResMed Inc.

Via GlobeNewswire

Study Estimates a 23% Increase in COPD by 2050, Representing 600 Million Patients Globally

December 07, 2023

From ResMed Inc.

Via GlobeNewswire

Senator's Bearish Tesla Bet Under Scrutiny As He Buys Put Options Ahead Of Elon Musk-Led Company's Q3 Results That Set Stock Slide In Motion ↗

November 17, 2023

Sen. Tommy Tuberville bought 3 tranches of put options to sell Tesla shares at $190 a day ahead of Q3 results that set in motion a stock slump.

Via Benzinga

Is NYSE:RMD a Good Fit for Dividend Investing? ↗

October 18, 2023

Analyzing RESMED INC (NYSE:RMD)'s Dividend Potential.

Via Chartmill

Expert Ratings for ResMed ↗

October 12, 2023

Via Benzinga

ResMed Adopts New Operating Model to Accelerate Long-term Growth

November 09, 2023

From ResMed Inc.

Via GlobeNewswire

2 Monster Stocks to Buy Without Any Hesitation ↗

November 07, 2023

Down 33% and 44%, these two stocks look too good to pass up today.

Via The Motley Fool

How Sleep Device Player ResMed Is Gaining Philips' Market Share In Flow Generator Market - Analysts Weigh In ↗

October 27, 2023

Needham analyst Mike Matson reiterated a Buy rating on ResMed Inc. (NYSE: RMD)

Via Benzinga

Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors Overreact? ↗

October 27, 2023

Makers of devices to treat obesity-related conditions have struggled recently. Analysts say there's more to the story.

Via Investor's Business Daily

ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2024

October 26, 2023

From ResMed Inc.

Via GlobeNewswire

Earnings Scheduled For October 26, 2023 ↗

October 26, 2023

Companies Reporting Before The Bell • TotalEnergies (NYSE:TTE) is likely to report quarterly earnings at $2.57 per share on revenue of $49.83 billion.

Via Benzinga

3 Stocks to Buy From the ‘Buy the Dip’ ETF ↗

October 23, 2023

It’s a lot harder than it looks to buy the dip. Using artificial intelligence to do this makes these three stocks a buy.

Via InvestorPlace

Topics Artificial Intelligence

Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2023 ↗

October 12, 2023

Via Benzinga

Exxon Mobil To Rally Around 23%? Here Are 10 Other Analyst Forecasts For Thursday ↗

October 12, 2023

Cantor Fitzgerald cut Hyliion Holdings Corp. (NYSE: HYLN) price target from $2 to $1. Cantor Fitzgerald analyst Andres Sheppard downgraded the stock from Neutral to Underweight. Hyliion shares fell...

Via Benzinga

ResMed to Report First Quarter Fiscal 2024 Earnings on October 26, 2023

October 05, 2023

From ResMed Inc.

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2023 ↗

September 29, 2023

Via Benzinga

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

20 21 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.